Bioxodes is a dynamic biotech start-up specialized in the development of novel therapeutics using molecules derived from nature to prevent thrombosis and inflammatory processes

NEWS : E. Godfroid, CEO and L. Camusot, business developer will represent Bioxodes at BIO-Europe Fall 2019.